http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102272788-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6874 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6863 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate | 2015-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-102272788-B1 |
titleOfInvention | Biomarker for predicting or monitoring effect of a c-Met inhibitor |
abstract | A biomarker for predicting and/or verifying the efficacy of a c-Met inhibitor, a composition for predicting and/or assaying the efficacy of a c-Met inhibitor including a detection material for the biomarker, c including a detection material for the biomarker -Met inhibitor application target selection composition, c-Met inhibitor efficacy prediction and / or efficacy verification method using the biomarker, c-Met inhibitor application target selection method using the biomarker, and the selected application target There is provided a method for preventing and/or treating cancer comprising administering a c-Met inhibitor to the . |
priorityDate | 2014-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 973.